(Redirected from Gamma-linolenic acid)
'gamma-Linolenic acid' (GLA) is an
omega-6 essential fatty acid found primarily in vegetable oils. It is sold as a dietary supplement for treating problems with
inflammation and auto-immune diseases. Such use is controversial.
Chemistry
In physiological literature, GLA is designated as 18:3(ω-6). Chemically, GLA is a
carboxylic acid with an 18-carbon chain and three ''
cis'' double bonds; the first double bond is located at the sixth carbon from the omega end. It is also sometimes called 'gamolenic acid'.
It is an
isomer of
alpha-linolenic acid, which is the
omega-3 fatty acid found in flax seed. Although there are alpha- and gamma- forms of linolenic acid, there is no beta form. One was once identified but it turned out to be an artifact of the original analytical process, (Gunstone).
Dietary Sources
GLA is obtained from vegetable oils, such as evening primrose (''
Oenothera biennis'') oil,
blackcurrant seed oil,
borage oil and
hemp seed oil, and from
spirulina, a
cyanobacteria. Each contains varying amounts of the fatty acid, with borage oil usually being the most heavily concentrated form. All are widely available in
pharmacies,
health food stores, or
online shops.
The human body produces GLA from
linoleic acid (LA). This reaction is catalized by Δ
6-
desaturase (D6D), an enzyme which allows the creation of a double bond on the 6th carbon counting from the carboxyl terminus. LA is consumed sufficiently in most diets, from such abundant sources as
cooking oils and
meats. However, a lack of GLA can occur when people grow older and their bodies become unable to produce it in sufficient quantities, or due to specific dietary deficiencies.
A Source of Eicosanoids
GLA is an
Omega-6 essential fatty acid.
From GLA, the body forms
dihomo-gamma-linolenic acid (DGLA).
This is one of the body's three sources of
eicosanoids (along with
AA and
EPA.)
DGLA is the precursor of the
prostaglandin PGH
1, which in turn forms PGE
1 and the
thromboxane TXA
1.
PGE
1 has a role in regulation of
immune system function and is used as the medicine
alprostadil.
TXA
1 modulates the pro-inflammatory properties of the thromboxane TXA
2.
Unlike AA and EPA, DGLA cannot yield
leukotrienes. However it can inhibit the formation of pro-inflammatory leukotrienes from AA, (Belch and Hill, 2000).
:''Although GLA is an ω-6 fatty acid (which are generally pro-inflammatory) it has anti-inflammatory properties; see discussion at
Essential fatty acid interactions - The paradox of dietary GLA.''
Health and Medicine

The seed oil of ''Oenothera biennis'' (evening primrose) is a source of GLA
GLA is sometimes prescribed in the belief that it has anti-
inflammatory properties lacking some of the common
side effects of other
anti-inflammatory drugs.
Herbal medicine advocates recommend GLA for
autoimmune disorders,
arthritis,
eczema and
PMS with noticeable results not expected for months. Conflicting data are found for GLA in the treatment of
eczema; but the UK's
Medicines and Healthcare products Regulatory Agency has withdrawn GLA's product licence for atopic eczema (Smith, 2003). Research is ongoing, investigating GLA as a potential
anticancer agent.
[1] GLA is unique among the omega-6
polyunsaturated fatty acids (linoleic acid, GLA and
arachidonic acid) in its potential to suppress tumor growth and metastasis (Fan and Chapkin, 1998).
The US
National Institute of Health's MedlinePlus states that there is 'B' grade evidence ('good scientific evidence') for the efficacy of
evening primrose oil in the treatment of
eczema and skin
irritation. But it cautions that large well-designed studies are still needed (NIH Medline Plus).
GLA can also form a
lithium salt, increasing its solubility in water. The resulting compound is Li-GLA, also called lithium gammalinolenate. Li-GLA is currently in phase II
clinical trials to determine whether it is useful in the treatment of
HIV infections, since it has the ability to destroy HIV-infected
T cells
in vitro. It has a number of side-effects, including a reduction in
hemoglobin,
hematuria,
gastrointestinal disturbance, fatigue and headache.
History
In the
Middle Ages, a
folk remedy would be to take
borage for any problems from
rheumatism to
heart disease.
The medical use of GLA has been controversial.
David Horrobin published much research on the use of GLA (as evening primrose oil) as a dietary supplement for treating
atopic eczema; (e.g. Horrobin, 2000). He also founded Scotia Pharmaceuticals, which sold this oil as a pharmaceutical, which led to controversy even after his death (Williams 2003).
References
1. Plant oil 'acts like cancer drug' (describing work by Dr Javier Menendez and colleagues at Northwestern University and published in ''Journal of the National Cancer Institute'').
★
Evening primrose oil and borage oil in rheumatologic conditions Belch, Jill JF and Hill, Alexander PubMed cite.
★
★ "DGLA itself cannot be converted to LTs but can form a 15-hydroxyl derivative that blocks the transformation of arachidonic acid to LTs. Increasing DGLA intake may allow DGLA to act as a competitive inhibitor of 2-series PGs and 4-series LTs and thus suppress inflammation."
★
Editorial: Evening primrose oil for atopic dermatitis—Time to say goodnight, Williams, Hywel C, , , BMJ, 13 Dec 2003 British Medical Journal summary editorial on evening primrose oil in the treatment of eczema
★
British Medical Journal: Efficacy and tolerability of borage oil in adults and children with atopic eczema.
★
''Importance of Dietary gamma -Linolenic Acid in Human Health and Nutrition'', Fan, Yang-Yi and Robert S. Chapkin, , , Journal of Nutrition, 9 September 1998
★ Gunstone, Frank,
Personal Communication at Peter Lapinskas' pages; URL Retrieved
3 February 2006
★
Essential fatty acid metabolism and its modification in atopic eczema, Horrobin, David, , , American Journal of Clinical Nutrition, January 2000
★
MedlinePlus Herbs and Supplements: Evening primrose oil NIH Medline Plus
See also
★
Linolenic acid